Skip to main content

Advertisement

Table 2 Baseline levels of the measured markers in the total population and according to the presence of low or high RPR

From: vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease

  Total population Low RPR (n = 741) High RPR (n = 258) p-value§
vWF (%) 105 (82, 133) 100 (79, 126) 124 (94, 145) < 0.001
ADAMTS13 antigen (ng/mL) 532 (461, 606) 537 (469, 613) 511 (448, 580) 0.001
ADAMTS13 activity (IU/mL) 1.03 (0.83, 1.19) 1.04 (0.84, 1.19) 0.99 (0.76, 1.16) 0.020
Ratio vWF/ADAMTS13 antigen 0.20 (0.15, 0.26) 0.19 (0.14, 0.25) 0.23 (0.18, 0.31) < 0.001
Ratio vWF/ADAMTS13 activity 107 (77, 152) 101 (73, 137) 127 (93, 192) < 0.001
Platelet count (× 109/L) 227 (195, 264) 224 (192, 261) 236 (200, 273) 0.010
  1. Values are given as median (25th, 75th percentiles)
  2. § p-values refer to differences between the groups with high or low RPR
  3. Significant p-values are highlighted with boldface